Para citar este trabalho use um dos padrões abaixo:
BCG is the only approved vaccine for tuberculosis (TB) prevention.Although effective in protecting newborns against disseminated TB,it does not protect adults against pulmonary TB.The objective of this project was to characterize how the TAM family receptor tyrosine kinases,AXL and MERTK,influence dendritic cell (DC) responses following BCG challenge.These receptors are associated with suppression of Toll-like receptor signaling, decreased expression of co-stimulatory molecules,and reduced production of pro-inflammatory cytokines.We hypothesized that blocking TAM receptors would enhance DC and CD4+ T lymphocyte activation,favoring the generation of long-lived memory cells.To test this hypothesis, we characterized MHC-II expression and cytokine production by AXL KO, MERTK KO,and C57BL/6 (WT) DCs,24h after in vitro BCG infection.We also performed co-culture of BCG-challenged DCs and CD4+ T lymphocytes bearing transgenic TCR specific for the immunodominant BCG antigen Ag85B.In vivo,AXL KO and C57BL/6 mice were vaccinated with BCG via subcutaneous and intravenous routes and challenged 2 months later with Mtb.AXL KO and MERTK KO DCs displayed increased MHC-II expression compared to WT cells.BCG increased TNF and IL-12p40 production in WT, AXL-KO,and MERTK-KO dendritic cells (DCs);TNF production was reduced in MERTK-KO DCs.BCG challenge induced IL-1β production in WT and AXL-KO DCs, but this was not detected in MERTK-KO DCs.WT, AXL-KO,and MERTK-KO BCG-infected DCs induced similar proliferation of BCG-specific CD4+ T lymphocytes,while double-KO BCG-infected DCs induced lower proliferation compared to all other groups.BCG vaccination reduced Mtb bacterial load in the lungs of C57BL/6 and AXL-KO mice,with no differences between mouse strains or vaccination routes.The data suggest that individual deletion of AXL and MERTK alters MHC-II expression and cytokine production after BCG challenge.However,blocking AXL alone was not to enhance protection against Mtb.FAPESP,CAPES,CNPq.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo